PUBLISHER: TechNavio | PRODUCT CODE: 1559415
PUBLISHER: TechNavio | PRODUCT CODE: 1559415
The needle-free injection systems market is forecasted to grow by USD 20153.3 mn during 2023-2028, accelerating at a CAGR of 16.83% during the forecast period. The report on the needle-free injection systems market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing preference for minimally invasive biopsies, increasing target population demanding needle-less injections, and rising demand for biosimilars and vaccines.
Technavio's needle-free injection systems market is segmented as below:
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 14.01% |
CAGR | 16.83% |
Incremental Value | $20153.3 mn |
By End-user
By Product
By Geographical Landscape
This study identifies the increasing incidence of needlestick infections as one of the prime reasons driving the needle-free injection systems market growth during the next few years. Also, rise in demand for self-administered injections and market expansion in emerging economies will lead to sizable demand in the market.
The report on the needle-free injection systems market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading needle-free injection systems market vendors that include Aijex Pharma International Inc., AKRA DERMOJET, Amico Group, ANTARES PHARMA INC., Becton Dickinson and Co., Crossject, Endo International Plc, Ferring BV, Inovio Pharmaceuticals Inc., Lepu Medical Technology Beijing Co. Ltd., Medbitz Pte Ltd., Mika Medical Co., Needle Free Injection System, NuGen Medical Devices, PharmaJet Inc., PORTAL INSTRUMENTS INC, QUINOVARE and TECHiJET, Recipharm AB, Technologies Medicales Internationales Inc., and West Pharmaceutical Services Inc.. Also, the needle-free injection systems market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: